(Q33643173)

28 July 2017

1 reference

title

Therapeutic aspects of polymorphic epithelial mucin in adenocarcinoma (English)

1 reference

28 July 2017

1 reference

Miles DW

1

1 reference

PubMed ID

10341360

28 July 2017

Taylor-Papadimitriou J

series ordinal

2

1 reference

28 July 2017

1 April 1999

1 reference

Pharmacology & Therapeutics

28 July 2017

1 reference

28 July 2017

82

1 reference

28 July 2017

97-106

1 reference

28 July 2017

1

1 reference

Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Making the most of mucin: a novel target for tumor immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Maintenance of clonal anergy by endogenously produced IL-10

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

A gene dosage effect is responsible for high overexpression of the MUC1 gene observed in human breast tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

MUC-1 epithelial tumor mucin-based immunity and cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

The polymorphic epithelial mucin: potential as an immunogen for a cancer vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Vaccination against tumor cells expressing breast cancer epithelial tumor antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Activation of cellular immunity after intracavitary monoclonal antibody therapy of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Enhancing the effect of THERATOPE STn-KLH cancer vaccine in patients with metastatic breast cancer by pretreatment with low-dose intravenous cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Peptide-based cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Expression of sialyl-Tn in gastric cancer: correlation with known prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Identification of human cancers deficient in antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Cellular characteristics of peripheral blood lymphocytes and tumour-infiltrating lymphocytes in patients with gynaecological tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Cell and environment interactions in tumor microregions: the multicell spheroid model

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

The human tumour-associated epithelial mucins are coded by an expressed hypervariable gene locus PUM

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Breast cancer immunology.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

Separation, phenotyping and limiting dilution analysis of T-lymphocytes infiltrating human solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2899%2900003-0

7 January 2021

10.1016/S0163-7258(99)00003-0

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10341360